AVACARE CLINICAL RESEARCH NETWORK
LIVE

Serial Number

88696815

Owner

QCare Site Services, Inc.

Attorney

Arlene D. Hanks

Filing Date

Nov 18, 2019

Add to watchlist:

No watchlists yet
View on USPTO

AVACARE CLINICAL RESEARCH NETWORK Trademark

Serial Number: 88696815 • Registration: 7055669

AVACARE CLINICAL RESEARCH NETWORK is a trademark filed by QCare Site Services, Inc. on November 18, 2019. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

QCare Site Services, Inc. (2 trademarks)

2400 Ellis Road
Durham, NC 27703

Entity Type: 03

Trademark Details

Filing Date

November 18, 2019

Registration Date

May 16, 2023

Published for Opposition

April 7, 2020

Goods & Services

Site management organization services, namely, business assistance services for other clinical research organizations, namely, new trial and study procurement, budgeting and contracting, business study feasibilities, creation and implementation of standard operating procedures, providing and managing study coordinators; development of comprehensive patient recruitment strategies; overseeing informed consent administration and management, namely, business administration and business management assistance for others; patient referral management, namely, business administration and business management assistance for others; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials, applications for drug approval and late phase and/or real world research studies; business data compilation and tracking services for others, namely, interactive tracking of clinical trial subject enrollment, status and adverse side effects of treatment and medication, including interactive services on mobile platform; business consulting services, namely, consulting regarding regulatory inspections and biopharmaceutical and biotechnology audits

Medical and scientific research, namely, conducting clinical trials and translational research for others; clinical research services during clinical trials of pharmaceuticals and medical devices, namely, data collection service using software to evaluate, analyze, and collect clinical data; multitherapeutic site management organization services, namely, research and development services in the field of pharmaceuticals and drug development

Filing History

OPPOSITION TERMINATED NO. 999999
May 24, 2023 OP.T
OPPOSITION DISMISSED NO. 999999
May 24, 2023 OP.D
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 16, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
May 16, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 12, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 11, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 25, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 24, 2023 AITU
USE AMENDMENT FILED
Mar 10, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 10, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 13, 2022 NOAM
OPPOSITION INSTITUTED NO. 999999
Jun 5, 2020 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
May 6, 2020 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 18, 2020 NONP
ASSIGNED TO LIE
Mar 5, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 27, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 27, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 27, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 27, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 27, 2020 CNEA
ASSIGNED TO EXAMINER
Feb 21, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 26, 2019 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 23, 2019 NWOS
NEW APPLICATION ENTERED
Nov 21, 2019 NWAP